Chicago Partners Investment Group LLC Boosts Stock Holdings in Agilent Technologies, Inc. $A

Chicago Partners Investment Group LLC grew its position in shares of Agilent Technologies, Inc. (NYSE:A) by 85.9% during the second quarter, Holdings Channel.com reports. The fund owned 3,632 shares of the medical research company’s stock after purchasing an additional 1,678 shares during the quarter. Chicago Partners Investment Group LLC’s holdings in Agilent Technologies were worth $434,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of A. Generation Investment Management LLP boosted its holdings in Agilent Technologies by 19.8% during the 1st quarter. Generation Investment Management LLP now owns 4,983,556 shares of the medical research company’s stock worth $582,976,000 after acquiring an additional 824,243 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in shares of Agilent Technologies by 18.7% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 3,836,105 shares of the medical research company’s stock worth $448,748,000 after buying an additional 604,124 shares during the last quarter. Mackenzie Financial Corp boosted its holdings in shares of Agilent Technologies by 141.5% in the 1st quarter. Mackenzie Financial Corp now owns 935,893 shares of the medical research company’s stock worth $109,481,000 after buying an additional 548,344 shares during the last quarter. Woodline Partners LP boosted its holdings in shares of Agilent Technologies by 681.6% in the 1st quarter. Woodline Partners LP now owns 522,073 shares of the medical research company’s stock worth $61,072,000 after buying an additional 455,276 shares during the last quarter. Finally, Nordea Investment Management AB boosted its holdings in shares of Agilent Technologies by 16.2% in the 2nd quarter. Nordea Investment Management AB now owns 3,213,748 shares of the medical research company’s stock worth $383,143,000 after buying an additional 447,207 shares during the last quarter.

Agilent Technologies Trading Up 0.2%

Shares of A opened at $146.01 on Thursday. The business’s 50-day moving average price is $129.24 and its 200-day moving average price is $118.56. Agilent Technologies, Inc. has a twelve month low of $96.43 and a twelve month high of $153.84. The stock has a market cap of $41.39 billion, a PE ratio of 34.27, a P/E/G ratio of 4.76 and a beta of 1.26. The company has a quick ratio of 1.71, a current ratio of 2.25 and a debt-to-equity ratio of 0.53.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share for the quarter, meeting the consensus estimate of $1.37. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.The firm had revenue of $1.74 billion for the quarter, compared to analysts’ expectations of $1.67 billion. During the same period in the prior year, the business posted $1.32 earnings per share. The company’s revenue was up 10.1% on a year-over-year basis. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. On average, equities analysts forecast that Agilent Technologies, Inc. will post 5.58 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, October 22nd. Stockholders of record on Tuesday, September 30th were given a dividend of $0.248 per share. The ex-dividend date was Tuesday, September 30th. This represents a $0.99 annualized dividend and a dividend yield of 0.7%. Agilent Technologies’s dividend payout ratio is currently 23.24%.

Analyst Ratings Changes

A number of equities analysts recently weighed in on A shares. Rothschild & Co Redburn started coverage on shares of Agilent Technologies in a report on Wednesday, October 8th. They issued a “buy” rating and a $165.00 price target on the stock. Evercore ISI boosted their price target on shares of Agilent Technologies from $128.00 to $140.00 and gave the stock an “in-line” rating in a report on Tuesday, October 7th. JPMorgan Chase & Co. boosted their price target on shares of Agilent Technologies from $155.00 to $165.00 and gave the stock an “overweight” rating in a report on Thursday, October 9th. Rothschild Redb raised shares of Agilent Technologies to a “strong-buy” rating in a report on Wednesday, October 8th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Agilent Technologies in a report on Wednesday, October 8th. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and six have given a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $149.62.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.